Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9-amino-20(s)-camptothecin
2. 9-amino-20-camptothecin, (+-)-isomer
3. 9-amino-20-camptothecin, (r,s)-isomer
4. 9-amino-cpt
5. Nsc 603071
1. 91421-43-1
2. Aminocamptothecin
3. 9-amino-camptothecin
4. 9-amino-cpt
5. 9-amino-20(s)-camptothecin
6. 9-amino-20-(s)-camptothecin
7. Nsc-603071
8. Nsc603071
9. 5mb77ice2q
10. Chembl274070
11. (s)-10-amino-4-ethyl-4-hydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
12. Chebi:80755
13. (s)-10-amino-4-ethyl-4-hydroxy-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
14. Camptothecin, 9-amino-
15. (19s)-8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
16. (s)-10-amino-4-ethyl-4-hydroxy-1,12-dihydro-14h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h)-dione
17. 10-amino-4(s)-4-ethyl-4-hydroxy-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione
18. 10-amino-4(s)-4-ethyl-4-hydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
19. Mls002702905
20. Unii-5mb77ice2q
21. Nsc 603071
22. Idec-132
23. Nsc-629971
24. 9-aminocamptothecan
25. 9-amino Camptothecin
26. 9-nh2-camptothecin
27. 9-amino-2(s)-camptothecin
28. Schembl26578
29. (s)-10-amino-4-ethyl-4-hydroxy-1h-pyrano(3;,4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione
30. Cid_72402
31. Mls000728575
32. 9-aminocamptothecin [mi]
33. Dtxsid10873202
34. Hms2220k11
35. Hms3339h11
36. Hms3749c03
37. 10-amino-4-ethyl-4-hydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
38. Bcp09002
39. Ex-a4335
40. 9-amino-cpt (9-aminocamptothecin)
41. Bdbm50008936
42. Mfcd00909855
43. S2653
44. Zinc37866089
45. 9-aminocamptothecin [who-dd]
46. Akos015896595
47. Cs-7784
48. Db12515
49. Ncgc00247552-01
50. 1h-pyrano(3;,4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 10-amino-4-ethyl-4-hydroxy-, (s)-
51. Ac-33991
52. As-14292
53. Nci60_004578
54. Smr000445687
55. Hy-100309
56. F11420
57. 421a431
58. A843867
59. J-504140
60. Brd-k09291936-001-07-5
61. Q27149808
62. (s)-10-amino-4-ethyl-4-hydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
63. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 10-amino-4-ethyl-4-hydroxy-, (4s)-
64. 1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione,4-ethyl-4-hydroxy-9-nitro-
65. 1h-pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione, 10-amino-4-ethyl-4-hydroxy-, (s)-
Molecular Weight | 363.4 g/mol |
---|---|
Molecular Formula | C20H17N3O4 |
XLogP3 | 0.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 1 |
Exact Mass | 363.12190603 g/mol |
Monoisotopic Mass | 363.12190603 g/mol |
Topological Polar Surface Area | 106 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 775 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?